Modulation of polymorphonuclear leukocyte apoptosis in the critically ill by removal of cytokines with continuous hemodiafiltration.
Delay of polymorphonuclear leukocyte (PMN) apoptosis caused by hypercytokinemia is considered to be a potential cause of tissue damage and resultant organ failure. We evaluated whether continuous hemodiafiltration using a polymethylmethacrylate membrane hemofilter (PMMA-CHDF), which can remove cytokines in the circulating blood, can modulate apoptosis in peripheral blood neutrophils and thereby reduce tissue damage and organ dysfunction in 25 critically ill patients. Following the completion of a 3-day PMMA-CHDF session, serum cytokine levels were significantly decreased and the percentage of apoptotic PMNs was significantly increased. A significant correlation was observed between the PMMA-CHDF-induced increase in the percentage of apoptotic PMNs and the degree of decrease in the serum interleukin-6 level. A significant correlation was also found between the increase in the percentage of apoptotic PMNs and improvement in sequential organ failure assessment score following PMMA-CHDF. These results suggest that PMMA-CHDF in critically ill patients with hypercytokinemia and concomitant delay in apoptosis of PMNs can alleviate the delay of PMN apoptosis through the removal of serum cytokines and thus may result in avoidance of organ dysfunction.
Hirano
Takeshi
T
Department of Emergency and Critical Care Medicine, Graduate School of Medicine, Chiba University, Chiba, Japan. t-hirano@tb3.so-net.ne.jp
Hirasawa
Hiroyuki
H
Oda
Shigeto
S
Shiga
Hidetoshi
H
Nakanishi
Kazuya
K
Matsuda
Ken-Ichi
K
Nakamura
Masataka
M
Asai
Takayoshi
T
Kitamura
Nobuya
N
D000328:Adult; D000368:Aged; D017209:Apoptosis; D016638:Critical Illness; D016207:Cytokines / Q000097:blood / Q000302:isolation & purification*; D005260:Female; D017583:Hemodiafiltration / Q000379:methods* / Q000592:standards; D006801:Humans; D015850:Interleukin-6 / Q000097:blood; D007958:Leukocyte Count; D008297:Male; D008875:Middle Aged; D009102:Multiple Organ Failure / Q000517:prevention & control; D009504:Neutrophils / Q000166:cytology*; D019904:Polymethyl Methacrylate / Q000627:therapeutic use; D016896:Treatment Outcome
D016207:Cytokines; D015850:Interleukin-6; D019904:Polymethyl Methacrylate